As of January 1, 2018Letter Agreement • March 8th, 2018 • Flexion Therapeutics Inc • Pharmaceutical preparations
We are pleased to offer you continued employment with Flexion Therapeutics, Inc. (the "Company"), as Chief Medical Officer, reporting to Michael Clayman. This letter agreement (the “Agreement”) replaces and supersedes the offer letter between you and the Company dated April 13, 2016.
As of January 1, 2018Flexion Therapeutics Inc • March 8th, 2018 • Pharmaceutical preparations
We are pleased to offer you continued employment with Flexion Therapeutics, Inc. (the "Company"), as Chief Regulatory Officer, reporting to Michael Clayman. This letter agreement (the “Agreement”) replaces and supersedes the offer letter between you and the Company dated October 14, 2014.
Mark Levine Dear Mark:Flexion Therapeutics Inc • March 8th, 2018 • Pharmaceutical preparations
We are pleased to offer you continued employment with Flexion Therapeutics, Inc. (the “Company”), as General Counsel and Corporate Secretary, reporting to Michael Clayman, Chief Executive Officer. This offer letter agreement (the “Agreement”) will replace and supersede in its entirety the offer letter agreement between you and the Company dated May 8, 2017.
